Table 2.
Incidence of adverse reactions
| Study | Adverse reaction | |
|---|---|---|
|
| ||
| E | C | |
| Zhu W 2020 [11] | Vaginal pain 1 case | Vaginal pain 1 case, pruritus 1 case, fever 1 case |
| Shun X 2022 [15] | Abdominal distension 3 cases, pruritus 2 cases, vaginal pain 2 cases | Abdominal distension 3 cases, pruritus 3 cases, vaginal pain 2 cases |
| Li C 2018 [16] | Vaginal uncomfortable 4 cases, fever 3 cases, urine frequency 2 cases | Vaginal uncomfortable 5 cases, fever 3 cases, urine frequency 3 cases |
| Liu H 2016 [17] | Irritability 1 case | Irritability 1 case, gastrointestinal reaction 1 case |
| Lai Z 2021 [18] | Vaginal pain 3 cases, vaginal dryness 2 cases | Vaginal pain 1 case, vaginal dryness 3 cases |
| Li X 2020 [19] | leucorrhea increasing 1 case, rash 1 case | leucorrhea increasing 2 cases, rash 1 case |
| Wang L 2021 [20] | Vaginal secretion increase 1 case, abnormal leukorrhea 2 cases, vaginal uncomfortable 2 cases | Vaginal secretion increase 3 cases, abnormal leukorrhea 4 cases, vaginal uncomfortable 6 cases |
| Lai X 2022 [21] | Vaginal uncomfortable 1 case, fever 1 case | Vaginal uncomfortable 3 cases, fever 2 cases, urine frequency 1 case |
| Yi B 2021 [22] | Vaginal pain 5 cases, abdominal distension 2 cases, vaginal secretion increase 1 case | Vaginal pain 3cases, abdominal distension 2 cases, vaginal uncomfortable 1 case, vaginal secretion increase 1 case |
| Zhou J 2020 [23] | Pruritus 1 case | Vaginal pain 2 cases, pruritus 3 cases, urine frequency 3 cases |
E: experimental group; C: control group.